| P2093 | author name string | Andrew D Yurochko | |
| | Ian B DeMeritt | |
| | Jagat P Podduturi | |
| | Maciej T Nogalski | |
| | A Michael Tilley | |
| P2860 | cites work | Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation | Q24650561 |
| | Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 |
| | Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway | Q28615706 |
| | Shaping the nuclear action of NF-kappaB | Q29614600 |
| | Inhibition of NF-kappa B by sodium salicylate and aspirin | Q29614708 |
| | The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 |
| | The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 |
| | Infection and atherosclerosis: emerging mechanistic paradigms | Q33696699 |
| | Cytomegalovirus is involved in vascular pathology | Q33762118 |
| | Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis | Q33762124 |
| | Cytomegalovirus and atherogenesis | Q33768702 |
| | Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant | Q33782001 |
| | Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts | Q33787378 |
| | The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression | Q33797024 |
| | Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling | Q33842473 |
| | Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein | Q34016717 |
| | The Rel/NF-kappa B family: friend and foe. | Q34023268 |
| | Series introduction: the transcription factor NF-kappaB and human disease | Q34116362 |
| | NF-kappaB signaling and human disease | Q34264609 |
| | Do pathogens accelerate atherosclerosis? | Q34389205 |
| | The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection | Q34743775 |
| | Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters | Q39879958 |
| | Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. | Q40481090 |
| | Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. | Q40584504 |
| | Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus | Q40595020 |
| | Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. | Q40677826 |
| | Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. | Q40707169 |
| | Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection | Q40967781 |
| | Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid | Q41107899 |
| | Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. | Q41565250 |
| | Productive infection of human endometrial stromal cells by human cytomegalovirus | Q43608447 |
| | Has cytomegalovirus infection any role in the development of atherosclerosis? | Q43792385 |
| | A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study | Q45741610 |
| | Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169. | Q45801980 |
| | A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus | Q48378635 |
| | Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1. | Q51604924 |
| | Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. | Q54071052 |
| | Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. | Q54641160 |
| | NF- B activation can mediate inhibition of human cytomegalovirus replication | Q56787221 |
| | Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients | Q67506305 |
| | Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration | Q71059480 |
| | Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo | Q73596145 |
| | High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis | Q74471681 |
| | Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression | Q77320669 |
| | Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression | Q34998851 |
| | Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle | Q35079311 |
| | High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis | Q35811381 |
| | Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters | Q35845633 |
| | UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells | Q35847129 |
| | Integrin alphavbeta3 is a coreceptor for human cytomegalovirus | Q35865693 |
| | The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. | Q35872328 |
| | The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection | Q35887796 |
| | Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection | Q36090467 |
| | Promoter-regulatory region of the major immediate early gene of human cytomegalovirus | Q36252923 |
| | Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products. | Q36621424 |
| | Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site | Q36680389 |
| | A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2 | Q36680417 |
| | Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. | Q36781988 |
| | The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site | Q36796246 |
| | Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains | Q36803353 |
| | Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter | Q36811230 |
| | Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region | Q36828401 |
| | Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. | Q36853873 |
| | trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus | Q36865895 |
| | Organization and expression of the immediate early genes of human cytomegalovirus | Q36905093 |
| | Structural analysis of the major immediate early gene of human cytomegalovirus | Q36911017 |
| | Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro | Q36944091 |
| | Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells | Q37093324 |
| | A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation | Q37248409 |
| | Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter | Q37422869 |
| | Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication | Q37596556 |
| | Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway | Q37683123 |
| | Possible role of cytomegalovirus in atherogenesis | Q37875443 |
| | NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation | Q38342724 |
| | Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity | Q38359214 |
| | A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency | Q39594664 |
| | Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes | Q39602194 |
| | Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication | Q39682884 |
| | ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences | Q39791161 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| | NF-κB | Q411114 |
| P304 | page(s) | 15-31 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression | |
| P478 | volume | 346 | |